Cranberry and Gut Health in Crohn's Disease

Recruiting Early Phase 1 Interventional Study
Crohn Disease (CD) Crohn Disease
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Basic Science
Participants needed
50 (estimated)
Sponsor
Ana Maldonado-Contreras · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is investigating whether a cranberry-based dietary supplement, rich in polyphenols and fiber, can enhance gut health in individuals with Crohn's disease. People with Crohn's disease often have an imbalance in their gut microbiome (the community of bacteria in the gut). Previous research suggests that cranberry compounds may help support beneficial gut bacteria. In this study, adults wi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult CD patients between 18 and 65 years old. * Women of childbearing potential will be required to use at least one form of "highly effective" contraception throughout the study. * Confirmed diagnosis of Crohn's disease. * CD activity lower than sCDAI\<450. * Moderate to sev…
Contacts

Madeline Johns

508-856-5279

MadelineNunez.Johns@umassmed.edu

CONTACT